Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Feb 2009 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Canara Robeco ELSS Tax Saver |
|---|---|
| 03 Feb 2009 | ₹100.00 |
| 22 Jul 2010 | ₹244.95 |
| 07 Jan 2012 | ₹221.85 |
| 24 Jun 2013 | ₹262.08 |
| 10 Dec 2014 | ₹435.13 |
| 27 May 2016 | ₹428.30 |
| 12 Nov 2017 | ₹554.76 |
| 29 Apr 2019 | ₹630.99 |
| 14 Oct 2020 | ₹727.24 |
| 01 Apr 2022 | ₹1101.54 |
| 17 Sep 2023 | ₹1283.73 |
| 04 Mar 2025 | ₹1457.65 |
| 20 Aug 2026 | ₹1743.70 |
| Metric | Canara Robeco · Regular NAV ₹181.17 Very High risk ★★★☆☆ | Category median ELSS · 51 funds |
|---|---|---|
| +2.73% | +2.06% | |
| +12.55% | +13.00% | |
| +10.69% | +12.22% | |
| +14.15% | +12.69% | |
| +17.70% | +13.09% | |
| +10.45% | — | |
| +15.03% | +14.73% | |
| +15.27% | +15.15% | |
| +14.59% | +14.10% | |
| Risk | ||
| 13.50% | 14.18% | |
| 0.45 | 0.47 | |
| 0.61 | 0.63 | |
| -34.33% | -37.97% | |
| Nifty 500 | — | |
| +0.80% | +0.84% | |
| 0.94 | 0.97 | |
| 99.5% | 100.1% | |
| 95.4% | 95.6% | |
| 1.84% | 1.93% | |
| ₹8,491Cr | ₹857.48Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 33% | 33% | |
| Shridatta Bhandwaldar | — | |
| 03 Feb 2009 | — | |
| 74 | — | |
| 38.3% | — | |
| 3.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.